Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial

This study has been completed.
Information provided by:
Khon Kaen University
ClinicalTrials.gov Identifier:
First received: May 19, 2006
Last updated: March 17, 2008
Last verified: October 2006
Primary insomnia patients will sleep with Quetiapine not better than without Quetiapine

Condition Intervention
Primary Insomnia
Drug: Quetiapine
Drug: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by Khon Kaen University:

Primary Outcome Measures:
  • Total Sleep Time [ Time Frame: 3 weeks ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Sleep Latency Period, Sleep satisfaction [ Time Frame: 3 weeks ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 16
Study Start Date: December 2006
Study Completion Date: August 2007
Arms Assigned Interventions
Experimental: A
Drug: Quetiapine
Placebo Comparator: B
Drug: placebo

Detailed Description:
  1. Primary insomnia will be diagnosed according to DSM-IV-TR
  2. After consenting, cases will be divided (double blind randomization)in to two arms 2.1 sleep hygiene with placebo group 2.2 sleep hygiene with Quetiapine group
  3. outcome measurement: sleep diary, sleep satisfaction visual analog scale and sleep satisfaction likert scale
  4. statistical method: dependent T test

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Primary insomnia Patients by DSM-IV-TR criteria
  • cases enrolled: age 18-65 educated

Exclusion Criteria:

  • Currently receiving Quetiapine or other hypnotic drugs
  • Liver disease
  • Patients with heart Dz, Hypertension, thyroid disease
  • History of epilepsy or febrile convulsion
  • pregnant
  • cognitive impairments
  • History of Orthostatic Hypotension
  • Patient with other Psychiatric conditions or Drug dependence
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00328822

Srinagarind Hospital, Khon Kaen University
Khon Kaen, Thailand, 40002
Sponsors and Collaborators
Khon Kaen University
Principal Investigator: Kanida Tassniyom, MD Department of Psychiatry, Faculty of Medicine, Khon Kaen University
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Faculty of Medicine, Khon Kaen University
ClinicalTrials.gov Identifier: NCT00328822     History of Changes
Other Study ID Numbers: HE490424 
Study First Received: May 19, 2006
Last Updated: March 17, 2008
Health Authority: Thailand: Ethical Committee

Keywords provided by Khon Kaen University:
Primary insomnia
Randomized controlled trial
Double blind

Additional relevant MeSH terms:
Sleep Initiation and Maintenance Disorders
Mental Disorders
Nervous System Diseases
Sleep Disorders
Sleep Disorders, Intrinsic
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents

ClinicalTrials.gov processed this record on May 04, 2016